{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T09:17:17Z","timestamp":1758273437562,"version":"3.37.3"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T00:00:00Z","timestamp":1664409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T00:00:00Z","timestamp":1664409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2023,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Given the wide spectrum of unique characteristics of macular neovascularization type 3 (MNV3) compared with types 1 and 2, we suggest regrading the colour photography assessment of the AREDS study to verify the impact of AREDS supplements on eyes with MNV3.<\/jats:p>","DOI":"10.1038\/s41433-022-02249-2","type":"journal-article","created":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T08:02:31Z","timestamp":1664438551000},"page":"1751-1753","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Do patients with unilateral macular neovascularization type 3 need AREDS supplements to slow the progression to advanced age-related macular degeneration?"],"prefix":"10.1038","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8147-1415","authenticated-orcid":false,"given":"Bilal","family":"Haj Najeeb","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7788-7311","authenticated-orcid":false,"given":"Ursula","family":"Schmidt-Erfurth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,9,29]]},"reference":[{"key":"2249_CR1","doi-asserted-by":"publisher","unstructured":"Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss. Arch Ophthalmol. 2001;119:1417. https:\/\/doi.org\/10.1001\/archopht.119.10.1417.","DOI":"10.1001\/archopht.119.10.1417"},{"key":"2249_CR2","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1055\/s-2006-926977","volume":"21","author":"LA Yannuzzi","year":"2001","unstructured":"Yannuzzi LA, Negr\u00e3o S, Lida T, Carvalho C, Rodriguez-Coleman H, Slakter J, et al. Retinal angiomatous proliferation in age-related macular degeneration. Retina. 2001;21:416\u201334. https:\/\/doi.org\/10.1055\/s-2006-926977.","journal-title":"Retina."},{"key":"2249_CR3","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1097\/00006982-200509000-00005","volume":"25","author":"NE Gross","year":"2005","unstructured":"Gross NE, Aizman A, Brucker A, Klancnik JM, Yannuzzi LA. Nature and risk of neovascularization in the fellow eye of patients with unilateral retinal angiomatous proliferation. Retina. 2005;25:713\u20138. https:\/\/doi.org\/10.1097\/00006982-200509000-00005.","journal-title":"Retina"},{"key":"2249_CR4","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1097\/01.iae.0000434566.57189.37","volume":"34","author":"M Sawa","year":"2014","unstructured":"Sawa M, Ueno C, Gomi F, Nishida K. Incidence and characteristics of neovascularization in fellow eyes of Japanese patients with unilateral retinal angiomatous proliferation. Retina. 2014;34:761\u20137. https:\/\/doi.org\/10.1097\/01.iae.0000434566.57189.37.","journal-title":"Retina"},{"key":"2249_CR5","doi-asserted-by":"publisher","unstructured":"Campa C, Harding SP, Pearce IA, Beare NAV, Briggs MC, Heimann H. Incidence of neovascularization in the fellow eye of patients with unilateral retinal angiomatous proliferation. Eye. 2010. https:\/\/doi.org\/10.1038\/eye.2010.88.","DOI":"10.1038\/eye.2010.88"},{"key":"2249_CR6","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1097\/IAE.0000000000002768","volume":"40","author":"TY Wong","year":"2020","unstructured":"Wong TY, Lanzetta P, Bandello F, Eldem B, Navarro R, Loevestam-Adrian M, et al. Current concepts and modalities for monitoring the fellow eye in neovascular age-related macular degeneration. Retina. 2020;40:599\u2013611. https:\/\/doi.org\/10.1097\/IAE.0000000000002768.","journal-title":"Retina"},{"key":"2249_CR7","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1097\/IAE.0000000000002603","volume":"40","author":"JH Kim","year":"2020","unstructured":"Kim JH, Kim JW, Kim CG, Lee DW. Influence of fellow-eye examination interval on visual acuity at fellow-eye neovascularization in unilateral type 3 neovascularization. Retina. 2020;40:1255\u201361. https:\/\/doi.org\/10.1097\/IAE.0000000000002603.","journal-title":"Retina"},{"key":"2249_CR8","doi-asserted-by":"publisher","unstructured":"Haj Najeeb B, Deak GG, Sacu S, Schmidt-Erfurth U, Gerendas BS. The RAP study, report 4: morphological and topographical characteristics of multifocal macular neovascularization type 3. Graefe\u2019s Arch Clin Exp Ophthalmol. 2021. https:\/\/doi.org\/10.1007\/s00417-021-05332-8.","DOI":"10.1007\/s00417-021-05332-8"},{"key":"2249_CR9","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1111\/aos.12437","volume":"92","author":"A Caramoy","year":"2014","unstructured":"Caramoy A, Ristau T, Lechanteur YT, Ersoy L, Mueller S, Gelisken F, et al. Environmental and genetic risk factors for retinal angiomatous proliferation. Acta Ophthalmol. 2014;92:745\u20138. https:\/\/doi.org\/10.1111\/aos.12437.","journal-title":"Acta Ophthalmol"},{"key":"2249_CR10","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.ophtha.2015.10.034","volume":"123","author":"E Daniel","year":"2016","unstructured":"Daniel E, Shaffer J, Ying G, Grunwald JE, Martin DF, Jaffe GJ, et al. Outcomes in eyes with retinal angiomatous proliferation in the comparison of age-related macular degeneration treatments trials (CATT). Ophthalmology. 2016;123:609\u201316. https:\/\/doi.org\/10.1016\/j.ophtha.2015.10.034.","journal-title":"Ophthalmology."},{"key":"2249_CR11","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1136\/bjophthalmol-2019-315311","volume":"105","author":"B Haj Najeeb","year":"2021","unstructured":"Haj Najeeb B, Deak GG, Schmidt-Erfurth UM, Gerendas BS. RAP study, report 1: novel subtype of macular neovascularisation type III, cilioretinal MNV3. Br J Ophthalmol. 2021;105:113\u20137. https:\/\/doi.org\/10.1136\/bjophthalmol-2019-315311.","journal-title":"Br J Ophthalmol"},{"key":"2249_CR12","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1097\/IAE.0000000000002774","volume":"40","author":"B Haj Najeeb","year":"2020","unstructured":"Haj Najeeb B, Deak G, Schmidt-Erfurth U, Gerendas BS. THE RAP STUDY, REPORT TWO: the regional distribution of macular neovascularization type 3, a novel insight into its etiology. Retina. 2020;40:2255\u201362. https:\/\/doi.org\/10.1097\/IAE.0000000000002774.","journal-title":"Retina"},{"key":"2249_CR13","doi-asserted-by":"publisher","unstructured":"Haj Najeeb B, Deak GG, Schmidt\u2010Erfurth U, Gerendas BS. The RAP study, report 3: Discoloration of the macular region in patients with macular neovascularization type 3. Acta Ophthalmol. 2021:aos.14866. https:\/\/doi.org\/10.1111\/aos.14866.","DOI":"10.1111\/aos.14866"},{"key":"2249_CR14","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1097\/IAE.0000000000000460","volume":"35","author":"M Marsiglia","year":"2015","unstructured":"Marsiglia M, Boddu S, Chen CY, Jung JJ, Mrejen S, Gallego-Pinazo R, et al. Correlation between neovascular lesion type and clinical characteristics of nonneovascular fellow eyes in patients with unilateral, neovascular age-related macular degeneration. Retina. 2015;35:966\u201374. https:\/\/doi.org\/10.1097\/IAE.0000000000000460.","journal-title":"Retina"},{"key":"2249_CR15","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1097\/IAE.0000000000000619","volume":"35","author":"JP Marques","year":"2015","unstructured":"Marques JP, La\u00edns I, Costa M\u00c2, Pires I, da luz Cachulo M, Figueira J, et al. Retinal angiomatous proliferation. Retina. 2015;35:1985\u201391. https:\/\/doi.org\/10.1097\/IAE.0000000000000619.","journal-title":"Retina"},{"key":"2249_CR16","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1097\/IAE.0000000000002198","volume":"38","author":"E Borrelli","year":"2018","unstructured":"Borrelli E, Souied EH, Freund KB, Querques G, Miere A, Gal-Or O, et al. Reduced choriocapillaris flow in eyes with type 3 neovascularization and age-related macular degeneration. Retina. 2018;38:1968\u201376. https:\/\/doi.org\/10.1097\/IAE.0000000000002198.","journal-title":"Retina"},{"key":"2249_CR17","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s00417-007-0705-3","volume":"246","author":"H Koizumi","year":"2008","unstructured":"Koizumi H, Iida T, Saito M, Nagayama D, Maruko I. Choroidal circulatory disturbances associated with retinal angiomatous proliferation on indocyanine green angiography. Graefe\u2019s Arch Clin Exp Ophthalmol 2008;246:515\u201320. https:\/\/doi.org\/10.1007\/s00417-007-0705-3.","journal-title":"Graefe\u2019s Arch Clin Exp Ophthalmol"},{"key":"2249_CR18","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1097\/IAE.0000000000002489","volume":"40","author":"JH Kim","year":"2020","unstructured":"Kim JH, Chang YS, Kim JW, Kim CG, Lee DW. Characteristics of type 3 neovascularization lesions. Retina. 2020;40:1124\u201331. https:\/\/doi.org\/10.1097\/IAE.0000000000002489.","journal-title":"Retina"},{"key":"2249_CR19","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1097\/IAE.0000000000003330","volume":"42","author":"B Haj Najeeb","year":"2022","unstructured":"Haj Najeeb B, Deak GG, Mylonas G, Sacu S, Gerendas BS, Schmidt-Erfurth U. THE RAP STUDY, REPORT 5: REDISCOVERING MACULAR NEOVASCULARIZATION TYPE 3: multimodal imaging of fellow eyes over 24 months. Retina. 2022;42:485\u201393. https:\/\/doi.org\/10.1097\/IAE.0000000000003330.","journal-title":"Retina"},{"key":"2249_CR20","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.ajo.2014.07.006","volume":"158","author":"JJ Jung","year":"2014","unstructured":"Jung JJ, Chen CY, Mrejen S, Gallego-Pinazo R, Xu L, Marsiglia M, et al. The incidence of neovascular subtypes in newly diagnosed neovascular age-related macular degeneration. Am J Ophthalmol. 2014;158:769\u2013779.e2. https:\/\/doi.org\/10.1016\/j.ajo.2014.07.006.","journal-title":"Am J Ophthalmol"},{"key":"2249_CR21","doi-asserted-by":"publisher","unstructured":"The age-related eye disease study system for classifying age-related macular degeneration from stereoscopic color fundus photographs: the age-related eye disease study report number 6. Am J Ophthalmol. 2001;132:668-81. https:\/\/doi.org\/10.1016\/S0002-9394(01)01218-1.","DOI":"10.1016\/S0002-9394(01)01218-1"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-022-02249-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-022-02249-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-022-02249-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T09:05:57Z","timestamp":1686906357000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-022-02249-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,29]]},"references-count":21,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["2249"],"URL":"https:\/\/doi.org\/10.1038\/s41433-022-02249-2","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"type":"print","value":"0950-222X"},{"type":"electronic","value":"1476-5454"}],"subject":[],"published":{"date-parts":[[2022,9,29]]},"assertion":[{"value":"4 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}